Cargando…
Tetravalent SARS-CoV-2 S1 Subunit Protein Vaccination Elicits Robust Humoral and Cellular Immune Responses in SIV-Infected Rhesus Macaque Controllers
The COVID-19 pandemic has highlighted the need for safe and effective vaccines to be rapidly developed and distributed worldwide, especially considering the emergence of new SARS-CoV-2 variants. Protein subunit vaccines have emerged as a promising approach due to their proven safety record and abili...
Autores principales: | Khan, Muhammad S., Kim, Eun, Hingrat, Quentin Le, Kleinman, Adam, Ferrari, Alessandro, Sammartino, Jose C, Percivalle, Elena, Xu, Cuiling, Huang, Shaohua, Kenniston, Thomas W., Cassaniti, Irene, Baldanti, Fausto, Pandrea, Ivona, Gambotto, Andrea, Apetrei, Cristian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055053/ https://www.ncbi.nlm.nih.gov/pubmed/36993692 http://dx.doi.org/10.1101/2023.03.15.532808 |
Ejemplares similares
-
Tetravalent SARS-CoV-2 S1 subunit protein vaccination elicits robust humoral and cellular immune responses in SIV-infected rhesus macaque controllers
por: Khan, Muhammad S., et al.
Publicado: (2023) -
SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice
por: Kim, Eun, et al.
Publicado: (2023) -
Pharmacokinetics and Immunological Effects of Romidepsin in Rhesus Macaques
por: Kleinman, Adam J., et al.
Publicado: (2020) -
Emergence of resistance mutations in simian immunodeficiency virus (SIV)-infected rhesus macaques receiving non-suppressive antiretroviral therapy (ART)
por: Policicchio, Benjamin Bruno, et al.
Publicado: (2018) -
So Pathogenic or So What?—A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research
por: Kleinman, Adam J., et al.
Publicado: (2022)